HOLOGIC INC. overview

Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to develop analyte specific reagents (ASRs) — the “active ingredients” of laboratory-developed tests used to identify specific diseases or conditions — that would aid in the detection of H5N1 bird flu. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241218942183/en/ Panther Fusion® system...

Hologic, Inc., (Nasdaq: HOLX) a global leader in women’s health focused on developing innovative medical technologies that effectively detect, diagnose and treat health conditions, today issued the following statement regarding the United States Preventive Services Task Force draft guidelines for cervical cancer screening: “Today’s recommendations are an important acknowledgement of the role of Pap testing combined with HPV testing, which is the gold standard of care and the most effective...

Hologic, Inc. (Nasdaq: HOLX) announced today that Martin Madaus has been elected to the Company’s Board of Directors, effective December 6, 2024. Dr. Madaus was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective December 6, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241209400549/en/ Dr. Martin Madaus (Photo: Business Wire) Dr. Madaus, who has more than 30 years of...

Four new studies regarding the Breast Cancer Index (BCI) test will be presented at the 2024 San Antonio Breast Cancer Symposium (SABCS). Among these studies, initial data will be premiered investigating the potential role of the BCI test to identify postmenopausal women with hormone-receptor positive (HR+), early-stage, node-negative disease who are at minimal risk of experiencing a distant recurrence. Full results will be shared during Poster Session 1 on December 11, 2024, at 12:30 p.m. CT...

Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI ® Detection 2.0 software across diverse patient populations at the 110 th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241202326112/en/ GAI 2.0 (Graphic: Business Wire) Artificial intelligence (AI) is increasingly used to aid in the...

Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110 th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago on December 1-5. On the show floor and during multiple workshops, Hologic will showcase AI-powered breast imaging advancements designed to assess breast density, enhance workflows and improve cancer detection. This press release features multimedia. View the full release here:...

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the following upcoming investor conferences: 2024 Stephens Annual Investment Conference in Nashville, TN on Thursday, November 21 st , at 10 a.m. Central Time (CT). 7 th Annual Evercore ISI HealthCONx Conference in Coral Gables, FL on Tuesday, December 3 rd , at 2:10 p.m. Eastern Time (ET). Citi’s 2024 Global Healthcare Conference in Miami, FL on Wednesday, December 4 th , at 8:45 a.m. ET. Each presentation will be...

Hologic Inc. President and CEO Steve MacMillan joins 'Mornings with Maria' to discuss his company's latest technological strides ......